Medical Newswire

Medical Newswire!

Medicine, Healthcare, Medical Research, Hospitals, Management
Press release distribution service
Home | Medical-Newswire.Com:

VFC's Stock House: Immunocellular Therapeutics May Be Immune To A Broad Market Downturn

(EMAILWIRE.COM, April 10, 2012 ) New York, NY -- With a new trading quarter upon us, the broad markets as a whole look ready to take a downswing after a strong first quarter and months of running higher as the global economy demonstrated a strength and resiliency not seen for years. Although a downswing - or "correction", as some might term it - could be in the works, there are some companies and stocks out there with enough pending news, catalysts and developments that may allow them to weather the storm and outperform the near-term market trends.



Immunocellular Therapeutics (IMUC) is one that has already well-outperformed the market this year and could maintain strength into any general downswing.



Over the course of the past six months Immunocellular has emerged from one of a quite few speculative Phase II cancer immunotherapy companies to become a potential front-runner in the next generation of such treatments.



Fueled by encouraging survival data from early trials and positive developments on the business front, IMUC has soared past the two dollar mark with ease and even breached the three dollar barrier for a period, a level that the share price still flirts with on a near-daily basis, even as the market as a whole is on a breather.



Other developments and pending catalysts also bode well for both the short and long term future of Immunocellular.



For full report visit: http://vfcsstockhouse.com/blog/article/-immunocellular-therapeutics-may-be-immune-to-a-broad-market-downturn



For this week's list of stocks to watch visit: http://vfcsstockhouse.com/blog/article/-weekly-stock-watch-april-9-13-ampe-pbth-imuc-nby-nriff-cndo-siga-imsc-yhoo-fb-siri-cvm-aapl-sbux-mcd-agen



For Tuesday's stock market roundup visit: http://vfcsstockhouse.com/blog/article/-tuesday-morning-roundup-facebook-yhoo-aol-msft-imsc-ctso-cpst-sppi-amrn-cldx-ampe



About VFCsStockHouse.com:



VFC's Stock House is an information and research outlet that brings new ideas to the table and opens discussions for a broad spectrum of investors, with a strong focus on - but not limited to - biotech stocks and the pharmaceutical and healthcare sectors. VFC's Stock House provides individual company profiles, write-ups and reports as well as giving general insights into broader-market news through various 'Stock Watch' lists. At the conclusion of most weeks, VFC's Stock House issues a "Weekly Stock Watch" that examines news items, stocks and stories that made headlines during the previous trading week, but may also make headlines or influence trends during the upcoming week as well. The information contained within the pages of VFCs Stock House are not intended to be taken as advice, but as a starting point where investors can follow up with their own DD and devise their own entry and exit strategies.



Follow VFC's Stock House on Twitter: https://twitter.com/#!/VFCsStockHouse



'Like' VFC's Stock House on Facebook: http://www.facebook.com/pages/VFCs-Stock-House/143724412345213



For full disclaimer visit: http://vfcsstockhouse.com



VFC's Stock House
VFC
240-786-2111
vfc@vfcsstockhouse.com

Source: EmailWire.com


Medical Resources
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Healthcare resource center today to browse our selection of 600+ complimentary Healthcare magazines, white papers, webinars, podcasts, and more. Get popular titles including:

Eyecare Business
Medical Laboratory Observer
FierceHealthcare

No credit cards, coupons, or promo codes required. Try it today!

Medical Sponsors

Health News
Health News Headlines - Yahoo News
Health News Headlines - Yahoo News
Get the latest health news headlines from Yahoo News. Find breaking health news, including analysis and opinion on top health stories.

Afghan police investigate gas poisoning at girls' school
31 Aug 2015 at 6:45am
More than 100 girls were taken to hospital from their school in western Afghanistan on Monday after breathing in toxic gas, officials said, and police were investigating whether the incident was deliberate. Elements of Afghanistan's ultra-conservative society oppose education for girls and schools have periodically come under attack. Police promised to track down those responsible.

Bristol-Myers buys rights to acquire fibrosis drug developer
31 Aug 2015 at 6:41am
(Reuters) - Drugmaker Bristol-Myers Squibb said it bought rights to a mid-stage fibrosis drug and its privately held developer for up to $1.25 billion, boosting its pipeline for drugs that treat tissue scarring. The deal gives Bristol-Myers access to Promedior Inc's lead experimental drug, PRM-151, which is being tested to treat two types of fibrosis. PRM-151 is undergoing trials as a treatment for the lung condition, idiopathic pulmonary fibrosis, and a form of blood disorder called myelofibrosis.


30 Lessons I've Learned In 30 Years
31 Aug 2015 at 5:24am

My healthy observations over the past 30 years of life. About your body, eating, work and living your dreams.Some I practice daily and others I've only recently discovered. I'm certainly no saint, though I've learned a thing or two...I hope for this list to inspire, entertain and maybe even motivate you to react. In whichever way feels right.30...


7 Unexpected Signs You're Totally Stressed
31 Aug 2015 at 5:19am
Also on HuffPost:

Medtronic says trials find gene linked to sudden cardiac death
31 Aug 2015 at 4:56am
(Reuters) - Two studies have identified a gene associated with potentially fatal abnormal heart rhythms, device maker Medtronic Plc said on Monday. The studies evaluated genetic information to identify gene abnormalities that may be associated with heart rhythms that could cause sudden cardiac death, the company said. Sudden cardiac death (SCD) is an unexpected death caused by the loss of heart function.

Asterias's stem cell therapy shows promise in study
31 Aug 2015 at 4:15am
Asterias Biotherapeutics Inc said initial data from a small study showed that its lead stem cell therapy could improve mobility in patients paralyzed by a spinal cord injury. Its success is a key step toward proving that embryonic stem cell research could cure diseases such as cancer, Parkinson's and serious health conditions such immune deficiencies, stroke and spinal injuries. Data showed that the severity of the spinal injury was reduced in the first patient and two other patients were able to resume their rehabilitation programs soon after being injected with the stem cells.


Spanish-style siesta could reduce blood pressure, medications
31 Aug 2015 at 3:06am

Taking midday naps as they do in Spain was associated with lower blood pressure and the need for fewer antihypertensive medications in a new study. "Although William Blake affirms that it is better to think in the morning, act at noon, eat in the evening and sleep at night, noon sleep seems to have beneficial effects," says Dr. Manolis Kallistratos of the Asklepieion Voula General Hospital in Athens, Greece, referring to the renowned British poet. Working with 386 middle-aged patients, 200 of whom were men and 186 were women, Dr. Kallistratos and his team set out to tackle the question of whether a midday siesta - which has all but disappeared in many Western cultures - could be beneficial.



Bayer heart failure drug cuts deaths in mid-stage trial
31 Aug 2015 at 2:19am

Bayer will move a heart failure drug into final-stage testing this year, boosting its ambitions in cardiovascular treatments after the experimental medicine showed a "striking" reduction in deaths in a mid-stage trial. Having done well with recently launched drugs such as stroke prevention pill Xarelto and eye treatment Eylea, the German company is eager to show it has another potential billion-dollar-plus winner in heart drug finerenone. Finerenone, which is still several years from reaching the market, is an improved version of a troublesome class of heart drugs called mineralocorticoid receptor antagonists (MRAs).


Insurers say private Medicare plans are better, but we really don't know
31 Aug 2015 at 2:00am
Commentary: lack of data makes it impossible to know if Medicare Advantage is better than government program

Texas teen dies of rare brain-eating amoeba infection
30 Aug 2015 at 4:57pm
(Reuters) - A Texas teenager who contracted a rare brain-eating disease after swimming in a lake about 70 miles (110 km) north of Houston has died, according to his family and local media. The 14-year-old Michael Riley Jr., a junior Olympian and honor student, seemed to have contracted the disease after he went swimming on Aug. 13 with his track team, his father Mike Riley told KTRK earlier this week. "It is with a heavy heart, that we let everyone know that Michael John Riley Jr. lost his battle on this earth but won a victory for his place in the arms of our Lord Jesus Christ," the family said in a statement on their Facebook page late on Saturday night.

Five more California inmates diagnosed with Legionnaires' disease
30 Aug 2015 at 4:47pm
Five of the inmates are being treated at outside hospitals after they were diagnosed with the disease through tests conducted over the last several days, the California Department of Corrections and Rehabilitation said in a statement. On Friday, the state announced that an inmate at the San Francisco-area prison was diagnosed with the disease and about 20 others showed symptoms of pneumonia, prompting officials to shut off water service at the institution. Legionnaires' disease, a severe form of pneumonia, is caused by inhaling mist infected with the bacteria Legionella.

Dead woman tests positive for Ebola in Sierra Leone
30 Aug 2015 at 1:34pm
The body of a woman who died in Sierra Leone has tested positive for the Ebola virus, less than a week after the last person confirmed to have had the disease was released from hospital, health officials said. In the latest case, a 67-year-old woman from the Kambia District along Sierra Leone's border with Guinea, died on Saturday. Sierra Leone's chief medical officer Brima Kargbo told Reuters that two samples tested in Kambia had tested positive for Ebola.

Neurologist, author Oliver Sacks dies at age 82
30 Aug 2015 at 11:12am
Oliver Sacks, the neurologist who studied the intricacies of the brain and wrote eloquently about them in books such as "Awakenings" and "The Man Who Mistook His Wife for a Hat," died on Sunday at the age of 82, his personal assistant said. The British-born Sacks, who announced in February that he had terminal liver cancer, died at his home in New York City at 1:30 a.m. with his partner, the writer Billy Hayes, and his personal assistant, Kate Edgar, at his side, Edgar told Reuters. "He definitely wrote to the very end," said Edgar, noting Sacks in his final days never stopped penning a legacy that will be published posthumously and may include "several books." NYU School of Medicine, where Sacks taught, said in a statement mourning his death that his "breakthrough work" in the fields of neurology and neuro psychiatry led to important understandings in these fields.

Sierra Leone: Officials confirm new Ebola death
30 Aug 2015 at 9:36am
FREETOWN, Sierra Leone (AP) ? Health officials in Sierra Leone on Sunday confirmed an Ebola death less than a week after the country's last known patient was discharged from a hospital.


Ghana strike ends but election campaign to test IMF deal further
30 Aug 2015 at 7:11am

By Matthew Mpoke Bigg ACCRA (Reuters) - Ghana faced down the first major challenge to an IMF austerity programme on Monday when doctors suspended a three-week strike but a bigger test of President John Mahama's commitment will come next year as he fights for reelection. The International Monetary Fund deal is designed to restore fiscal stability and kickstart growth in a country that recently lost its reputation as one of Africa's strongest economies after years in which its GDP grew at around 8 percent thanks to exports of gold, cocoa and oil. The end of the strike by the Ghana Medical Association makes it easier for the government to honour the $918 million IMF programme in the short-term.


Pharmanewswire.com is part of GropWeb Network, online properties of GroupWeb Media LLC. Copyright GroupWeb Media LLC. All Rights Reserved.

For unlimited press release distribution for $99 per month, call (281) 645-4086 or start posting your press releases online at EmailWire.com. CityRegions.Com is part of GropWeb Network, online properties of GroupWeb Media LLC. Copyright 2012 GroupWeb Media LLC. All Rights Reserved.


GroupWeb Media Network
AfricaNewswire.Net | AppleNews247.Com | AsiaNewsWire.Net | Aviation-NewsWire | Energy Industry | EstateNewsWire | Entertainment-NewsWire.com | Food Beverage News | Glamour NewsWire | Health NewsWire | Hosting NewsWire | i-Auto NewsWire | i-Business News | EuropeNewsWire.Net | iCameroon.com | i-Canada-News.Com | i-SoftwareNews.com | iT-NewsWire.Com
| InvestorsNewsDesk.Com | i-TravelNewsWire.Com | LegalLaw247.com | Medical-NewsWire.com | MiningNewsWire.net | MoneyNewsWire.Net | Movie-Stars-News.Com | PayDayNews247.Com | PharmaNewsWire.Com | Publishing-NewsWire.Com | Shopping-NewsWire.com | Telecom-NewsWire.Net | Transportation-News.Com | USGovernment-News.Com | WebPosters.Net | Wireless-NewsWire.Com |
Medical-Newswire.com - Medicl Newswire and Press Release service of GroupWeb Media LLC